ERBB2 and breast cancer: At immunohistochemistry, tumor cells were positive for the human epidermal growth factor receptor 2 (HER2) (Figure 1E) and cytokeratin 7 and negative for hormonal receptors (HR), consistent with the diagnosis of a metastasis from a HR‐/HER2+ BC.